# Lexaria Bioscience Corp. (LEXX) — Revenue

## Annual Revenue (USD)

| Year | Revenue |
| --- | --- |
| 2025 | $705,923 |
| 2024 | $464,278 |
| 2023 | $226,208 |
| 2022 | $255,397 |
| 2021 | $722,738 |
| 2020 | $384,543 |
| 2019 | $222,610 |
| 2018 | $433,287 |
| 2017 | $63,639 |
| 2016 | $40,718 |

## Quarterly Revenue (USD)

| Quarter | Revenue |
| --- | --- |
| 2026-02-28 | $20,000 |
| 2025-11-30 | — |
| 2025-05-31 | $174,000 |
| 2025-02-28 | $174,000 |
| 2024-11-30 | $183,923 |
| 2024-05-31 | $84,000 |
| 2024-02-29 | $145,000 |
| 2023-11-30 | $151,278 |
| 2023-05-31 | $77,707 |
| 2023-02-28 | $20,025 |
| 2022-11-30 | $97,735 |
| 2022-05-31 | $99,717 |
| 2022-02-28 | $30,650 |
| 2021-11-30 | $13,880 |
| 2021-05-31 | $204,055 |
| 2021-02-28 | $192,006 |
| 2020-11-30 | $295,656 |
| 2020-05-31 | $36,423 |
| 2020-02-29 | $37,549 |
| 2019-11-30 | $10,332 |
| 2019-05-31 | $59,931 |
| 2019-02-28 | $15,349 |
| 2018-11-30 | $22,209 |
| 2018-05-31 | $140,340 |

Source: [MarketCapTrends](https://marketcaptrends.com/company/LEXX/revenue)